NTx Bio Expands Manufacturing Footprint in North Texas
|
Dallas Innovates was the first to announce that Bio Nature's Toolbox Inc. (NTx Bio) will be launching a new biomanufacturing facility in Plano, bringing over 170 high-skilled jobs and strengthening North Texas’ position as a rising hub for biotech innovation. The facility will support the development of advanced RNA and protein-based therapies, fueling growth in the region’s life sciences workforce and research capabilities.
|
Local News Features New GMP Program at DeSoto ISD
|
DeSoto ISD has officially launched its first cohort of students in a new Pharmaceutical Manufacturing program at DeSoto High School.
In partnership with Dallas College and Panthera BioSolutions, and funded by the DeSoto Development Corporation, the four-week cGMP course offers hands-on training, college credit, and a direct pathway into North Texas’ growing biotech industry.
|
Lantern Pharma Receives FDA Clearance for
LP-184 Trial in Triple Negative Breast Cancer
|
Lantern Pharma has received FDA clearance to begin a Phase 1b/2 clinical trial of LP-184 in Triple Negative Breast Cancer (TNBC). This follows Orphan Drug Designation (2023) and Fast Track Designation (2024). With limited treatment options and average survival of just 10–18 months for metastatic TNBC, LP-184 targets a critical unmet need in a market exceeding $4B annually.
|
New Central Hub for Biotech and Life Science Roles
Across the State of Texas
|
Discover exciting opportunities in biotech, engineering, healthcare, and beyond through our curated job board. Whether you are just starting out or looking to take the next step in your career, this site connects you with high-impact roles at leading organizations across the region.
Launched in 2023, the BioWorks for North Texas Training Program continues to equip students with essential skills in Good Manufacturing Practices (GMP) and prepares them for in-demand, entry-level roles across the biotech and healthcare sectors.
We extend our sincere thanks to our grant partners for their continued support and dedication to advancing workforce development and industry growth across the region.
|
CX Precision Medicine and Other Female-Led Companies
Win Big at Ignite’s Golden Ticket Pitch
|
(from left to right) Ignite's Golden Ticket winners: Margo Harrison, MD, MPH of Wave Bye,
Danguole Altman, MBA of Cx Precision Medicine and Lauren Gage, MBA of Triplemoon
|
Ignite’s Golden Ticket Pitch Competition drew a vibrant crowd, showcasing seven trailblazing, female-led healthcare startups tackling healthcare’s biggest challenges. The event, featuring a powerhouse panel of judges, kicked off Ignite’s 2025 Golden Ticket Programs—designed to support female founders in precision medicine, AI-driven devices, and women’s health innovations.
The top three founders from each region won entry into Ignite’s Annual Accelerator Program, providing them with the essential support needed to scale their companies and achieve market success. The Golden Ticket Programs serve as a critical gateway to Ignite’s Accelerator, identifying the best and brightest female founders shaping the future of healthcare.
|
MassChallenge Announces 2025 Healthcare Cohort at Showcase
|
Congratulations to our member companies, ClearSight Therapeutics and OncoSeer Diagnostics, Inc., for being selected to join the MassChallenge Healthcare cohort and for the opportunity to pitch their innovations to leading investors. Their selection is a testament to the groundbreaking work they’re doing in healthcare and their growing impact on the North Texas innovation ecosystem. We’re proud to support these visionary teams as they continue to develop solutions that have the potential to transform patient care and advance health outcomes on a global scale.
|
From Discovery to Impact:
Shaping the Life Science Ecosystem in Tyler
May 20, 2025
|
Join BioNTX on May 20th in Tyler, TX, for the second annual symposium focused on Building a Life Science Entrepreneurial Ecosystem. This event will highlight groundbreaking biomedical research and address crucial topics, including intellectual property, funding strategies, and entrepreneurial success. Attendees will gain valuable insights into the growth of the region’s life science industry and its role in shaping the future of healthcare and innovation.
|
Exploring Cutting-Edge Lab Solutions
at Pegasus Park with Avantor
June 4, 2025
|
Join BioNTX and Avantor at Pegasus Park for an exclusive opportunity to explore the latest advancements in research lab solutions tailored to your organization’s needs. This unique event will feature a dynamic showcase of vendors presenting cutting-edge tools and technologies that support every stage of research, development, and production.
Spanning industries from biotech to pharmaceuticals, these solutions are designed to drive greater efficiency, precision, and innovation. Don’t miss this chance to connect with industry leaders, discover what’s next in scientific advancement, and be part of the conversation shaping the future of research.
|
Building Tomorrow's Life Sciences Workforce:
Regional Collaborations for Success
June 11, 2025
|
North Texas is home to a thriving life sciences ecosystem, and the future looks even brighter with the growing talent pool. Join the BioNTX Facilities Committee as we explore how regional partnerships between manufacturers, higher education institutions, and K-12 STEM educators are shaping a workforce primed for success. This session will highlight the innovative efforts driving workforce development and positioning North Texas as a leader in life sciences.
|
Showcasing Life Sciences in DFW at
BIO International 2025
June 16 - 19, 2025
|
BioNTX in collaboration with the leading Texas BIO organizations will be showcasing the strength of the Texas life science community at the BioTexas Pavilion, Booth #2665.
Join us to learn more about BioNTX and to connect with the innovators driving life sciences forward in Texas. From 9,200+ life science companies to leading research institutions and the world’s largest medical center, Texas is a global force in biotech and healthcare innovation.
|
Leverage Australia’s Advantage to
Accelerate Early-Phase Clinical Trials
June 25, 2025
|
Join BioNTX as we welcome an Australian delegation to Dallas. Discover how Australia’s fast regulatory process, quality systems, and cost incentives make it a top choice for early-phase clinical trials. Learn how engaging with Australia can accelerate your clinical trials.
|
Thank you for your support
|
Chronic Disease Day Gathers Leaders
and Patient Advocates
July 10, 2025
|
BioNTX and Good Days invite you to an exclusive luncheon symposium on Thursday, July 10 at Pegasus Park, bringing together senior leaders in biotech and healthcare, patient advocates, and key community stakeholders.
This gathering will spotlight urgent federal priorities in chronic illness care, unveil new regional partnerships, and explore bold opportunities to expand access to breakthrough treatments.
|
OncoNano Medicine Advances Precision Cancer Treatment
|
Southlake-based OncoNano Medicine is at the forefront of next-generation cancer diagnostics and therapeutics. The company’s lead innovation, a pH-activated imaging agent, enables real-time visualization of tumors during surgery, enhancing precision and improving outcomes.
In addition to its imaging technology, OncoNano is developing a portfolio of tumor-activated immunotherapies designed to minimize off-target effects while maximizing therapeutic impact. With multiple programs advancing through clinical development, OncoNano continues to position North Texas as a hub for cutting-edge oncology innovation.
|
Lantern Pharma Accelerates Precision Oncology
with AI-Driven Breakthroughs and Clinical Progress
|
Lantern Pharma is a clinical-stage oncology company advancing precision drug development through its proprietary radar AI platform, now powered by over 200 billion oncology data points. CEO Panna Sharma described Q1 2025 as a pivotal quarter, highlighting strong clinical progress—especially nearing full enrollment in the LP-184 Phase 1a trial by June 2025—and plans to launch its AI platform with a freemium model to foster collaborations and growth.
|
Solenic Medical Treats First Patient in Clinical Trial
for Non-Invasive Implant Infection Therapy
|
Solenic Medical Inc. has treated the first patient in its early feasibility clinical trial using its investigational Alternating Magnetic Field (AMF) technology. The novel, non-invasive approach targets biofilms on infected implants, aiming to reduce the need for revision surgeries in patients with prosthetic joint infections (PJIs).
The Sola2 AMF Knee System is being evaluated for safety in patients undergoing DAIR procedures at Medical City Plano. This milestone marks a major step toward transforming infection management in joint replacements.
|
NCTM Partners with Matica Biotechnology to
Accelerate Cell and Gene Therapy Development
|
The National Center for Therapeutics Manufacturing (NCTM) has partnered with Matica Biotechnology, a specialized contract development and manufacturing organization (CDMO) for cell and gene therapies (CGT), to create a comprehensive, end-to-end service platform. This collaboration will support CGT developers from early research through IND submission, clinical development, and commercialization, all within College Station, Texas.
|
Pharma.Aero and TIACA Drive Air Cargo Solutions
for Health and Agriculture
|
Pharma.Aero and TIACA (The International Air Cargo Association) have partnered on the Food and Farm for Health project to highlight the economic value and dual role of air cargo in improving healthcare access and fostering economic development in low- and middle-income countries. Developed in collaboration with CCA (The Cool Chain Association) and HLA (The Humanitarian Logistics Association), the project aims to maximize air cargo’s potential to deliver life-saving medicines while also supporting local agricultural economies.
|
Perkins&Will and Taubman College Establish Robin Guenther
Memorial Scholarship for Sustainable Healthcare Architecture
|
Perkins&Will and the University of Michigan’s Taubman College have established the Robin Guenther Memorial Scholarship, providing multi-year, need-based support to graduate architecture students pursuing a Master of Architecture at Taubman College, Guenther’s alma mater. Guenther, a leader in sustainable healthcare architecture and a passionate advocate for diversity and inclusion, passed away in May 2023.
|
Polsinelli Recognized for Excellence
in Pharmaceutical Industry Legal Services
|
Polsinelli is proud to be featured in the 2025 edition of BTI Consulting Group’s Most Recommended Law Firms guide, earning a spot among the top 18 law firms for the pharmaceutical industry. The annual report is based on over 300 interviews with top legal decision-makers at major global organizations. Polsinelli’s multidisciplinary Life Sciences Practice was recognized for its ability to meet the unique needs of clients in the pharmaceutical sector, offering comprehensive legal services across all stages of the lifecycle.
|
UTD Big Idea Competition Recognizes
Student and Alumni Innovations
|
(from left to right) Orikeda Trashi and Ikeda Trashi won the student track and $12,000 in the Big Idea Competition. The twin sisters and chemistry doctoral students founded Biodelivera.
|
Students and alumni from the University of Texas at Dallas showcased their innovative ideas in biotechnology, artificial intelligence, sustainability, and digital community-building at the Big Idea Competition finals, hosted by the Institute for Innovation and Entrepreneurship (IIE). Since its inception in 2007 at the Naveen Jindal School of Management, the competition awarded over $62,000 this year and received a record-breaking 125+ applications.
Biodelivera, developed by twin chemistry doctoral students Ikeda and Orikeda Trashi, took first place in the student competition, winning a $12,000 prize. Their platform, designed to deliver cancer therapy directly to tumors using virus-like particles, offers a novel solution to precisely target cancer cells, infiltrating tumor tissues deeply while being cost-effective. "This is a game changer for cancer therapy," said Ikeda Trashi during their pitch.
|
UTARI Research Assistant Program Enhances
UTA Engineering Student’s Career Path
|
The University of Texas at Arlington provides students with top-tier classroom instruction and valuable hands-on experience.
Connor Berberek, a mechanical engineering major graduating Friday during the College of Engineering’s 7 p.m. commencement ceremony at Globe Life Field, took full advantage of UTA’s undergraduate research opportunities by working with researchers at the UTA Research Institute (UTARI) in Fort Worth this spring. There, he assisted in fabricating and testing composite materials—materials that combine multiple substances to enhance strength and durability. This experience not only enriched his coursework but also solidified his decision to pursue a career in mechanical engineering.
|
UTA Researchers to be Honored for
Groundbreaking Work in Radiation Therapy
|
(from left to right) Zui Pan, PhD, Yuijie Chi, PhD,
Yingjie Liu, PhD, MD, and Joshua Rajan
|
New research from The University of Texas at Arlington, focused on improving the effectiveness of radiation therapy for cancer and other diseases.
The research team developed a system to study alpha radiation, exploring both its potential for treating cancer and the risks it might pose in other situations, such as space travel. The system is designed to be adjustable, allowing scientists to control the amount, speed, and method of radiation delivery. This flexibility makes it suitable for applications ranging from cancer therapy to low-level radiation exposure.
|
UT Southwestern Breaks Ground on
Cutting Edge Cancer Campus in Fort Worth
|
UT Southwestern Medical Center has officially broken ground on a Radiation Oncology campus in Fort Worth, ushering in a new era of cutting-edge cancer care for the city and surrounding communities. The new 65,000-square-foot facility will offer the most advanced therapies available, including Fort Worth's first MRI-guided precision radiation treatment, positioning it as a regional hub for cancer care. The campus is set to meet the growing demand for radiation oncology services, helping ensure access to world-class treatment for years to come. Scheduled to open in 2028, the new facility will be closely connected to UT Southwestern’s Moncrief Cancer Institute, further strengthening the area's cancer care infrastructure.
|
UT Southwestern and Children's Health to
Build New Pediatric Hospital in Dallas
|
UT Southwestern Medical Center and Children’s Health have announced a significant step forward in pediatric healthcare with the groundbreaking of a new pediatric campus in Dallas, which began construction in October 2024. Set to open in 2031, the new facility will be dedicated to meeting the growing demand for pediatric healthcare, research, and training in the region.
This new campus will significantly enhance the ability of UT Southwestern and Children’s Health to provide world-class care, advance medical research, and train the next generation of pediatric specialists. The expansion will help address the increasing need for comprehensive pediatric services, ensuring that children and families in Texas have access to the best possible healthcare.
|
FUNDING & MENTORSHIP OPPORTUNITIES
|
JumpStart Microgrants
Application closes May 31, 2025
|
JumpStart Microgrants are designed to empower undergraduate students across the Texas Tech University System with early-stage funding to advance their innovative ideas. Open to students in any discipline, these microgrants provide essential support for transforming concepts into functional prototypes.
The JumpStart program helps bridge the critical gap between ideation and execution. Through seed funding, mentorship opportunities, and access to resources at the Texas Tech Innovation Hub, undergraduates are equipped to validate ideas, test feasibility, and create working prototypes.
|
Grant Opportunity for Physician-Scientists:
Up to $2M Plus Expert Drug Development Support
Letter of Intent due June 4, 2025
|
Harrington Discovery Institute at University Hospitals is now accepting Letters of Intent for the 2026 Harrington Scholar-Innovator Award, which offers physician-scientists at accredited institutions in the U.S. and Canada a $100,000 guaranteed grant, expert drug and business development support, and the opportunity to compete for up to $300,000 in acceleration funds and up to $2 million in investment funding, while retaining intellectual property rights; Letters of Intent are due by June 4, 2025, with invited full applications due August 4, 2025.
|
Fueling Texas' Future in Cancer Research:
CPRIT Faculty Recruitment Award
Applications due June 20, 2025
|
The Cancer Prevention and Research Institute of Texas (CPRIT) offers funding to help Texas institutions recruit top early-career researchers pursuing their first tenure-track faculty appointment. The award supports innovative cancer research and strengthens Texas’ leadership in prevention, treatment, and discovery—particularly in priority areas like cancer disparities, childhood cancers, hepatocellular cancer, and computational oncology.
|
DoD Breast Cancer Clinical Research Extension
Application closes June 27, 2025
|
The fiscal year 2025 (FY25) Breast Cancer Research Program (BCRP) Clinical Research Extension Award aims to extend or expand the data collection, follow-up, and analysis of breast cancer clinical studies. The intent of this award mechanism is to increase the clinically relevant impact of breast cancer patient participation in clinical research by addressing the knowledge lost due to early trial termination, limited patient follow-up, or suboptimal sample and/or data collection and analysis. Applications must address at least one of the FY25 BCRP overarching challenges, unless adequate justification for exception is provided.
|
DoD Breast Cancer Era of Hope Scholar Award
Application closes June 27, 2025
|
Supports individuals who are early in their careers with significant potential to effect meaningful change in breast cancer. As the intent of the fiscal year 2025 (FY25) Breast Cancer Research Program (BCRP) Era of Hope Scholar Award is to recognize creative and innovative individuals rather than projects, the central features of the award are the demonstrated ability of the Principal Investigator (PI) to go beyond conventional thinking in their field and the innovative contributions that they can make toward ending breast cancer. PIs should be exceptionally talented scientists that are among “the best and the brightest” in their field(s), have demonstrated experience forming effective partnerships and collaborations, and exhibit strong potential for future leadership in breast cancer research. Applications must address one of the FY25 BCRP overarching challenges, unless adequate justification for exception is provided.
|
Advancing Early-Stage Innovation in Rare Cancers
Application closes July 1, 2025
|
The Fiscal Year 2025 (FY25) Rare Cancers Research Program (RCRP) Idea Development Award (IDA) supports innovative, early-stage research ideas with the potential to generate impactful data and open new avenues for investigation.
|
Funding Bold Ideas to Advance
Duchenne Muscular Dystrophy Research
Letter of Intent due July 25, 2025
|
The FY25 Duchenne Muscular Dystrophy Research Program (DMDRP) Idea Development Award (IDA) is designed to spark bold, early-stage research with the potential to transform the landscape of Duchenne muscular dystrophy (DMD). This award supports high-risk, high-reward ideas that are conceptually innovative and could lead to groundbreaking discoveries or new research directions that significantly improve outcomes for individuals living with DMD.
|
Fueling the Next Generation of Health Innovators
Application closes March 6, 2026
|
The One Health Incubator is a dynamic partnership between the Innovation Hub and the Health Sciences Center, created to support researchers and technology startups in the life sciences sector. This collaborative platform combines institutional expertise to offer an ecosystem of incubation, mentorship, and strategic connections—tailored specifically for life science innovators.
Startups and researchers benefit from access to state-of-the-art facilities, specialized resources, and guidance from industry experts. The incubator helps accelerate the development and commercialization of innovative healthcare solutions while fostering valuable relationships with potential partners, investors, and mentors.
|
NIH Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions
Program ends January 8, 2027
|
The purpose of this Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions is to support small scale research grants at institutions that do not receive substantial funding from the NIH, with an emphasis on providing biomedical research experiences primarily for undergraduate students, and enhancing the research environment at applicant institutions.
|
Nominate a North Texas Life Sciences Leader
for the 2025 iC³ Dennis K. Stone Award
Nominations due on July 1, 2025
|
(from left to right) Kristin Lonergan, CIC of Champion Commercial Insurance and 2024 DKS recipient Jeff Keyser, PhD, RPh, JD of Renibus Therapeutics
|
BioNTX honors individuals who have made significant contributions to the North Texas biotechnology industry through the Dennis K. Stone Award. This recognition celebrates those who have advanced life science research and inspired others to do the same.
Nominees should meet the following criteria:
-
Industry Growth & Innovation: Contributed to the formation and growth of multiple North Texas-based life science businesses.
- Generosity: Donated time, resources, or funds to support the North Texas life science community.
- Mentorship & Inspiration: Inspired and mentored others, fostering the continued growth of the North Texas life science industry.
-
Regional Advocacy: Actively championed the region as a thriving hub for successful life science ventures.
|
iC³ SUMMIT NEWS & UPDATES
|
Save The Date: September 2025
|
The iC³ Life Science Summit is an event that brings together leaders and innovators from the life sciences and healthcare sectors to discuss challenges, discover new opportunities, and drive transformation.
As we look ahead to the 2025 iC³ Life Science & Healthcare Innovation Summit, we are celebrating “10 Years and Beyond” with a focus on the cutting-edge intersection of biology, technology, and artificial intelligence (AI). This convergence is powering breakthroughs in precision medicine, biomanufacturing, and other fields shaping the future of healthcare.
|
Dates
Tuesday, September 16: 7:00am - 7:00pm
Wednesday, September 17: 8:00am - 3:00pm
|
Location
Hilton Anatole
2201 N Stemmons Freeway, Dallas, TX 75207
|
Recognizing the Next Generation of
Life Science & Healthcare Innovators
Nominations due on July 1, 2025
|
BioNTX is proud to spotlight emerging leaders in life sciences and healthcare innovation through the Rising Stars program at the iC³ Summit. This program honors entrepreneurs, startups, and researchers making a significant impact.
Nominees should meet the following criteria:
- Emerging entrepreneurs
- Innovative startups & early-stage companies
- Researchers driving groundbreaking advancements
- Organizations with ≤ $100M in funding or sales
|
Applications Now Open for the 4th Annual Tech Transfer
Showcase at BioNTX's iC³ Life Science Summit
Application closes on July 28, 2025
|
Present your groundbreaking innovations at the 4th Annual Tech Transfer Showcase during BioNTX's iC³ Life Science Summit, an exclusive platform designed to connect academic institutions from Texas, Arkansas, Louisiana, New Mexico, Oklahoma, and Tennessee with top industry leaders and investors.
This event offers a unique opportunity to highlight your most promising intellectual property, explore potential collaborations, and secure funding, all while advancing the future of life sciences and technology.
|
Upcoming Events & Opportunities
|
2025 Building a Life Science Entrepreneurial Ecosystem
Join BioNTX and the UT Tyler School of Medicine to hear groundbreaking research and explores key topics like intellectual property, and entrepreneurial success stories.
May 20th | Tyler, TX
|
2025 TechConnex by USICOC DFW
Join USICOC to be part of the action at the Annual Tech Conference in the heart of the DFW metro area! This event brings together top minds in technology, offering opportunities for networking, learning, and collaboration.
May 22nd | Plano, TX
|
AiCHE Dallas Section Meeting
Join AiCHE for their Dallas Section meeting where Dr. James Muhitch will speak about Clinical Trials 101: An Introduction to Drug Development and Clinical Research.
May 27th | Dallas, TX
|
Rare Disease, Real Impact: How a Nameless Disease Created a Community at SLC6A1 Connect
Join UTSW's Biotech Club for a panel discussion with SLC6A1 Connect. They will be hosting panelists Amber N. Freed, Kim Fry, and Whitney Feldman MHA, mothers and leaders from SLC6A1 Connect.
May 30th | Dallas, TX
|
The Werk Wagon: The Future of Manufacturing Workforce Development
Join TMAC and Meet the Werk Wagon, a fully equipped mobile training lab, helping manufacturers tackle real workforce challenges. Whether you’re struggling to find skilled workers or exploring mobile upskilling options, this event offers a glimpse into the future of workforce development, delivered right to your facility.
June 3rd | Dallas, TX
|
Scientific Research Innovation Showcase and Supplier Expo
Join BioNTX and Avantor to explore the latest research lab solutions that support your organization's needs. The event will feature a variety of vendors showcasing innovative tools and technologies across every stage of research, development, and production.
June 4th | Dallas, TX
|
Thank you for your Membership & Support!
"Those who contemplate the beauty of the earth find reserves of strength that will endure as long as life lasts."
- Rachel Carlson
|
|
